Cell surface CD43 determination improves diagnostic precision in late B‐cell diseases
Authors:
- 6 February 2003
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 120 (3) , 496-499
Abstract
Panels of immunological markers are useful in refining diagnosis in view of certain variability between B-cell leukaemias. A statistical multivariate approach was used on 100 B leukaemias (preliminary sample) to explore the potential value of the combination of CD43, and the classical markers CD5, CD23, CD79b, FMC7, CD22 and surface immunoglobulin to differentiate chronic lymphoid leukaemia (CLL) from lymphoma (non-CLL). CD43 was highly effective (P < 0.00001) and its inclusion in the panels improved the accuracy of discrimination in a 'control' sample of 74 B leukaemias to 98.6%. Inclusion of CD43 facilitates the diagnosis of B-lymphoproliferative disorders and improves their classification.Keywords
This publication has 9 references indexed in Scilit:
- World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997Journal of Clinical Oncology, 1999
- Frequency of CD43 Expression in Non-Hodgkin Lymphoma: A Survey of 742 Cases and Further Characterization of Rare CD43+Follicular LymphomasAmerican Journal of Clinical Pathology, 1999
- Improvement of the Chronic Lymphocytic Leukemia Scoring System With the Monoclonal Antibody SN8(CD79b)American Journal of Clinical Pathology, 1997
- The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disordersLeukemia Research, 1996
- Mantle cell lymphoma-- an entity comes of ageBlood, 1996
- The Utility of Flow Cytometric Immunophenotypic Analysis in the Distinction of Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia From Mantle Cell LymphomaAmerican Journal of Clinical Pathology, 1996
- CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: A three-color flow cytometric studyCytometry, 1995
- A Scoring System for the Classification of CD5- B CLL versus CD5+ B CLL and B PLLLeukemia & Lymphoma, 1995
- The Value of Scoring Systems for the Diagnosis of Biphenotypic Leukemia and Mature B-Cell DisordersLeukemia & Lymphoma, 1994